Get the Stockscreener App
0.7481
3.94%
-0.0307
After Hours:
.73
-0.0181
-2.42%
Immunic Inc stock is traded at $0.7481, with a volume of 2.24M.
It is down -3.94% in the last 24 hours and down -23.53% over the past month.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
See More
Previous Close:
$0.7788
Open:
$0.7849
24h Volume:
2.24M
Relative Volume:
1.64
Market Cap:
$73.80M
Revenue:
-
Net Income/Loss:
$-93.61M
P/E Ratio:
-0.3545
EPS:
-2.11
Net Cash Flow:
$-71.16M
1W Performance:
-10.41%
1M Performance:
-23.53%
6M Performance:
-34.95%
1Y Performance:
-37.13%
1-Day Range:
$0.7262
$0.7854
1-Week Range:
$0.7262
$0.8699
52-Week Range:
$0.561
$1.42
Immunic Inc Stock (IMUX) Company Profile
Name
Immunic Inc
Sector
Industry
Phone
(332) 255-9818
Address
1200 AVENUE OF THE AMERICAS, NEW YORK
Compare IMUX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.7481 | 76.83M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Mar-25-25 | Initiated | William Blair | Outperform |
| Nov-25-24 | Initiated | H.C. Wainwright | Buy |
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
| Aug-27-24 | Initiated | B. Riley Securities | Buy |
| Oct-21-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-19-22 | Resumed | H.C. Wainwright | Buy |
| Apr-15-21 | Initiated | Aegis Capital | Buy |
| Mar-24-21 | Initiated | JMP Securities | Mkt Outperform |
| Oct-02-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-20 | Initiated | Piper Sandler | Overweight |
| Aug-07-20 | Resumed | ROTH Capital | Buy |
| Jul-20-20 | Initiated | BMO Capital Markets | Outperform |
| Jun-05-20 | Initiated | Wedbush | Outperform |
| May-11-20 | Initiated | H.C. Wainwright | Buy |
| Mar-25-20 | Initiated | ROTH Capital | Buy |
| Jul-11-19 | Initiated | Chardan Capital Markets | Buy |
View All
Immunic Inc Stock (IMUX) Latest News
Will Immunic Inc. (10VA) stock outperform global peersSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Forecasting Immunic Inc. price range with options data2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Is Immunic Inc. stock a top momentum playJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
Evaluating Immunic Inc. with trendline analysis2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
What does recent volatility data suggest for Immunic Inc.2025 Key Lessons & AI Driven Price Predictions - newser.com
Is Immunic Inc. (10VA) stock a momentum leader2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Is Immunic Inc. stock resilient to inflationTrade Signal Summary & Technical Pattern Based Signals - newser.com
What high frequency data says about Immunic Inc.July 2025 Levels & Real-Time Stock Entry Alerts - newser.com
News impact scoring models applied to Immunic Inc.Volume Spike & Daily Growth Stock Tips - newser.com
Will Immunic Inc. stock see PE expansionWall Street Watch & Long-Term Investment Growth Plans - newser.com
Is Immunic Inc. (10VA) stock positioned for secular growthTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Immunic to Participate in Industry and Investor Conferences in November - Sahm
Immunic (IMUX) Price Target Decreased by 17.29% to 6.41 - MSN
Price momentum metrics for Immunic Inc. explainedJuly 2025 EndofMonth & Capital Protection Trading Alerts - newser.com
Immunic, Inc. (IMUX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
What sentiment indicators say about Immunic Inc. stockQuarterly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Immunic (IMUX) to Release Quarterly Earnings on Thursday - MarketBeat
Why Immunic Inc. (10VA) stock benefits from AI revolutionWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
Is Immunic Inc. stock supported by strong fundamentalsWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Is Immunic Inc. stock attractive for growth ETFs2025 Top Gainers & Fast Moving Stock Trade Plans - newser.com
EQS-News: Immunic to Participate in Industry and Investor Conferences in November - sharewise.com
EQS-News: Immunic AG: Immunic to Participate in Industry and Investor Conferences in November - FinanzNachrichten.de
Immunic (NASDAQ: IMUX) to join BIO-Europe Vienna and Jefferies London in November - Stock Titan
Immunic to participate in BIO-Europe and Jefferies Global Healthcare conferences in November - Proactive financial news
Will Immunic Inc. stock continue dividend increases2025 EndofYear Setup & Growth Focused Investment Plans - Fundação Cultural do Pará
Immunic Inc Stock (IMUX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):